Improving the penetration of ototopicals through tympanostomy tubes: Role of surfactants

International Journal of Pediatric Otorhinolaryngology

Volumn 72, Issue 1, 2008, Pages 69-72

  Reyes, Samuel A ^a   Smith, Lee P ^a   Younis, Ramzi T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Otitis media; Otorrhea; Ototopicals; Surfactant; Tympanostomy tube

Indexed keywords

BERACTANT; CIPROFLOXACIN; DEXAMETHASONE; DOCUSATE SODIUM; OFLOXACIN; SURFACTANT; TITANIUM; WATER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EARDRUM; IN VITRO STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; PRIORITY JOURNAL; TYMPANOSTOMY TUBE;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; BIOLOGICAL PRODUCTS; CIPROFLOXACIN; DEXAMETHASONE; DIOCTYL SULFOSUCCINIC ACID; MIDDLE EAR VENTILATION; MODELS, BIOLOGICAL; OFLOXACIN; SURFACE-ACTIVE AGENTS;

EID: 36649001378     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2007.09.014     Document Type: Article

References (10)

1. Oberman J.P., and Derkay C.S. Posttympanostomy tube otorrhea. Am. J. Otolaryngol. 25 (2004) 110-117
2. Garcia P., Gates G.A., and Schechtman K.B. Does topical antibiotic prophylaxis reduce post-tympanostomy tube otorrhea?. Ann. Otol. Rhinol. Laryngol. 103 (1994) 54-58
3. Daniel S.J., Kozak F.K., Fabian M.C., et al. Guidelines for the treatment of tympanostomy tube otorrhea. J. Otolaryngol. 34S2 (2005) S60-S63
4. Roland P.S., Stewart M.G., Hannley M., et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: introduction, methodology, and recommendations. Otolaryngol. Head Neck Surg. 130 (2004) S51-S56
5. Smith L.P., Smullen J.L., and Younis R.T. Differential penetration of ototopicals and water through tympanostomy tubes. Laryngoscope 115 (2005) 13671370
6. Singer A.J., Sauris E., and Viccellio A.W. Ceruminolytic effects of docusate sodium: a randomized, controlled trial. Ann. Emerg. Med. 36 (2000) 228-232
7. Wilson S.A., and Lopez R. Clinical inquiries. What is the best treatment for impacted cerumen?. J. Fam. Pract. 51 (2002) 117
8. Frohn A., and Roth N. Dynamics of Droplets (2000), Springer-Verlag, Berlin
9. Chen D.A., and Caparosa R.J. A nonprescription cerumenolytic. Am. J. Otol. 12 (1991) 475-476
10. van Iwaarden J.F., Claassen E., Jeurissen S.H., Haagsman H.P., and Kraal G. Alveolar macrophages, surfactant lipids, and surfactant protein B regulate the induction of immune responses via the airways. Am. J. Respir. Cell Mol. Biol. 24 (2001) 452-458